--(BUSINESS WIRE)--Spectrum Pharmaceuticals is a leading biotechnology company focused on acquiring, developing, and commercializing drug products, with a primary focus in hematology and oncology. Spectrum currently markets six hematology/oncology drugs, and has an advanced stage pipeline that has the potential to transform the company. Spectrum's strong track record for in-licensing and acquiring differentiated drugs, and expertise in clinical development have generated a robust, diversified, and growing pipeline of product candidates in advanced-stage Phase 2 and Phase 3 studies. More information on Spectrum is available at www.sppirx.com.
|
Company: |
SPECTRUM PHARMACEUTICALS | |||||
|
Headquarters Address: |
11500 S. Eastern Avenue #240 | |||||
| Henderson, NV 89052 | ||||||
|
Main Telephone: |
949-743-9244 | |||||
|
Website: |
||||||
|
Ticker: |
SPPI (Nasdaq) | |||||
|
Type of Organization: |
Public | |||||
|
Industry: |
Pharmaceuticals | |||||
|
Key Executives: |
President and CEO: Joseph Turgeon |
|||||
|
Contact: |
Shiv Kapoor | |||||
|
Phone: |
702-835-6300 | |||||
|
Email: |
||||||
